Healthcare & Life Sciences
Accro Bioscience
China
zombieseries-b
series-b
Stage
2
Investors
About
Accro Bioscience is a biopharmaceutical company focused on the research and development of innovative drugs targeting regulated cell death (RCD) pathways for treating major diseases like cancer and autoimmune disorders.
Explore Accro Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.